Croda Pharma — founded in 1925 — is a leading global chemical manufacturing partner specializing in the development and manufacture of innovative excipients and high-purity materials for pharmaceutical formulations. The company offers research grade materials and GMP-grade lipids for the discovery, clinical, and commercial manufacturing of mRNA vaccines and therapeutics. Key applications for their mRNA-enabling technologies include nonviral delivery through LNPs, lipoplexes, and cationic nano-emulsions.
